Amino acid residues in transmembrane segment IX of the Na+/I- symporter play a role in its Na+ dependence and are critical for transport activity
- PMID: 17606623
- DOI: 10.1074/jbc.M700147200
Amino acid residues in transmembrane segment IX of the Na+/I- symporter play a role in its Na+ dependence and are critical for transport activity
Abstract
The Na+/I- symporter (NIS) is a key plasma membrane glycoprotein that mediates Na+-dependent active I- transport in the thyroid, lactating breast, and other tissues. The OH group of the side chain at position 354 in transmembrane segment (TMS) IX of NIS has been demonstrated to be essential for NIS function, as revealed by the study of the congenital I- transport defect-causing T354P NIS mutation. TMS IX has the most beta-OH group-containing amino acids (Ser and Thr) of any TMS in NIS. We have thoroughly characterized the functional significance of all Ser and Thr in TMS IX in NIS, as well as of other residues in TMS IX that are highly conserved in other transporters of the SLC5A protein family. Here we show that five beta-OH group-containing residues (Thr-351, Ser-353, Thr-354, Ser-356, and Thr-357) and Asn-360, all of which putatively face the same side of the helix in TMS IX, plus Asp-369, located in the membrane/cytosol interface, play key roles in NIS function and seem to be involved in Na+ binding/translocation.
Similar articles
-
The Iodide Transport Defect-Causing Y348D Mutation in the Na+/I- Symporter Renders the Protein Intrinsically Inactive and Impairs Its Targeting to the Plasma Membrane.Thyroid. 2021 Aug;31(8):1272-1281. doi: 10.1089/thy.2020.0931. Epub 2021 Jun 4. Thyroid. 2021. PMID: 33779310 Free PMC article.
-
Asn441 plays a key role in folding and function of the Na+/I- symporter (NIS).FASEB J. 2013 Aug;27(8):3229-38. doi: 10.1096/fj.13-229138. Epub 2013 May 6. FASEB J. 2013. PMID: 23650190 Free PMC article.
-
The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.J Cell Sci. 2004 Feb 15;117(Pt 5):677-87. doi: 10.1242/jcs.00898. Epub 2004 Jan 20. J Cell Sci. 2004. PMID: 14734652
-
The Na+/I- symporter (NIS): recent advances.J Bioenerg Biomembr. 1998 Apr;30(2):195-206. doi: 10.1023/a:1020577426732. J Bioenerg Biomembr. 1998. PMID: 9672241 Review.
-
The sodium/iodide symporter: state of the art of its molecular characterization.Biochim Biophys Acta. 2014 Jan;1838(1 Pt B):244-53. doi: 10.1016/j.bbamem.2013.08.013. Epub 2013 Aug 27. Biochim Biophys Acta. 2014. PMID: 23988430 Review.
Cited by
-
Novel Compound Heterozygous Pathogenic Mutations of SLC5A5 in a Chinese Patient With Congenital Hypothyroidism.Front Endocrinol (Lausanne). 2021 Mar 19;12:620117. doi: 10.3389/fendo.2021.620117. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33815280 Free PMC article.
-
Molecular characterization of V59E NIS, a Na+/I- symporter mutant that causes congenital I- transport defect.Endocrinology. 2008 Jun;149(6):3077-84. doi: 10.1210/en.2008-0027. Epub 2008 Mar 13. Endocrinology. 2008. PMID: 18339708 Free PMC article.
-
Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter.Nat Commun. 2014 Jun 3;5:3948. doi: 10.1038/ncomms4948. Nat Commun. 2014. PMID: 24888603 Free PMC article.
-
The biology of the sodium iodide symporter and its potential for targeted gene delivery.Curr Cancer Drug Targets. 2010 Mar;10(2):242-67. doi: 10.2174/156800910791054194. Curr Cancer Drug Targets. 2010. PMID: 20201784 Free PMC article. Review.
-
Identification of a second substrate-binding site in solute-sodium symporters.J Biol Chem. 2015 Jan 2;290(1):127-41. doi: 10.1074/jbc.M114.584383. Epub 2014 Nov 14. J Biol Chem. 2015. PMID: 25398883 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources